In my role as Director of Clean Energy at Monolith, I have been at the forefront of developing and implementing strategies to secure clean electricity, which is essential for the company's qualification for clean hydrogen production tax credits and maintaining zero scope 2 carbon intensity. My responsibilities encompass:Strategic Planning: Developed a comprehensive strategy to ensure Monolith's clean electricity procurement aligns with eligibility for clean hydrogen production tax credits.Contract Negotiation: Led negotiations for infrastructure contracts with utilities, securing essential components like substations, transmission, and distribution lines to power our plant.Project Origination: Established a systematic process for engaging with potential partners in the industrial and energy sectors, facilitating discussions to deploy hydrogen at scale.Deal Structuring: Successfully brought multiple deals to the table with fully negotiated terms, enabling Monolith to recognize over $100 million in savings relative to initial proposals. These efforts have laid a strong foundation for future project development and partnerships.Carbon Market Leadership: Led efforts to integrate carbon accounting frameworks into clean energy procurement strategies, ensuring alignment with 45V requirements and accurate tracking of emissions reductions

Work with Utilities and Commercial & Industrial companies secure utility-scale renewable energy in Iowa and Illinois. Originated over 600 MWs of Solar, Wind, Battery Storage projects.

Manage NextEra Energy's international fleet of renewable and storage assets which consist of ~1 GW of wind, battery and thermosolar plants in Canada and Spain. Also manage solar and wind assets with C&I customers in California.

Help clients obtain the tax credits they rightly deserve

Oversaw RelayHealth's eVoucherRx solution, the leading electronic copay assistance program in the market. Facilitated >30% revenue and EBIT growth for a mature technology product. Responsible for the financial and technical health of the product which meant alignment across Sales, Development, Operations, Legal, Compliance, Marketing and Finance teams. Launched a first of a kind solution that provided copay assistance for patients who faced high deductibles and launched a interactive analytics portal for 200 plus Pharmaceutical Brands.

Assisted RelayHealth Clinical & the broader McKesson Connected Care & Analytics organization with various strategic finance initiatives. My primary responsibilities were helping the business think through the financial implications of new product launches, pricing of new and existing products, profitability analysis, and process improvement. I developed processes to review deal profitability, arrive at net new pricing, and make price modifications.

FP&A, US Oncology Network - April 2013 - September 2013Finance Manager, Global Sourcing and Corporate Procurement - September 2012 - March 2013Pricing and Profitability, RelayHealth Pharmacy - March 2012 - September 2012Revenue Accounting, McKesson Provider Technologies - September 2011 - March 2012.

Responsible for developing course content for Global Senior Commercial Finance Leadership training. Subjects that were covered included: 1. Value sharing between KO and its franchised bottlers2. New product, package, and equipment roll out processConducted Interviews of over 30 Finance Executives and Managers around the globe to understand how the aforementioned subjects were managed for their respective business units and/or regions. Information from the interviews was used to develop business cases, best practice matrix, and story board for future training.

Led and conducted audits of multi-billion dollar firm’s overseas subsidiaries (Australia, Colombia, Korea, and Mexico) and technical financial processes (derivative energy portfolio, corporate income tax, and cost savings program).Produced research-driven analysis creating more effective, risk-based audit for company’s North American and European millsLeadership roles included presenting senior management with recommendations on how to improve business processes and control environment, managing engagement teams, and holding class to teach colleagues on technical accounting issues and risk assessment methodologies

Researched and prepared company’s position on technical accounting matters and standards for internal documentation purposes as well as for external parties seeking information on standards application. (FAS 157 and FAS 133)Supervised company’s annual goodwill impairment analysis: reviewed forecasted income valuation models, collaborated with external valuation consultants and audit firms, and created summary write-up for company’s 10-K

Conducted and supervised audits for Mortgage Banks, Real Estate Funds, and small private companies. Worked extensively with Interest Rate Swaps, Embedded Derivatives, MBS investments, Bond Structures, and Loan Securitization